Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer

Podobne knjige/članki

• Phase III Trial to Evaluate the Efficacy of Maintaining Hemoglobin Levels above 120 G/DL with Erythropoietin vs above 100 G/DL without Erythropoietin in Anemic Patients Receiving Concurrent Radiation and Cisplatin for Cervical Cancer: A Gynecologic Oncology Group Study
  od: Thomas, Gillian, et al.
  Izdano: (2007)
• Blood transfusions in septic shock: is 7.0g/dL really the appropriate threshold?
  od: Mazza, Bruno Franco, et al.
  Izdano: (2015)
• Blood transfusions in septic shock: is 7.0g/dL really the appropriate threshold?
  od: Bruno Franco Mazza, et al.
  Izdano: (2015)
• Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin <10 g/dL
  od: Juan Carlos Ayus, et al.
  Izdano: (2005)
• Recovery from Extreme Hemodilution (Hemoglobin Level of 0.6 g/dL) in Cadaveric Liver Transplantation
  od: Kariya, Taro, et al.
  Izdano: (2015)